| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/08/2009 | CA2691750A1 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 01/08/2009 | CA2688313A1 Composition for mucosal administration containing agent for enhancing mucosal absorption of peptide drug, and administration method thereof |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011519A1 Process and apparatus for preparing a diagnostic or therapeutic agent |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2011516A1 Method of producing polymer micelle having low molecular chemical encapsulated therein |
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011488A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 01/07/2009 | EP2011484A2 Use of a dry powder composition of formoterol in the treatment of chronic obstructive pulmonary disease |
| 01/07/2009 | EP2011482A1 Solid preparation for oral application |
| 01/07/2009 | EP2011467A1 Fluid container and airless fluid dispensing system |
| 01/07/2009 | EP2011452A1 Injectable preparation for a muscle implant |
| 01/07/2009 | EP2010223A2 Hydrophilic polymer-conjugated lipids for peptide and protein folding disorders |
| 01/07/2009 | EP2010222A1 Pegylated factor viii |
| 01/07/2009 | EP2010221A2 Antibody-rnase-conjugate |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010219A2 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 01/07/2009 | EP2010149A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
| 01/07/2009 | EP2010148A2 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/07/2009 | EP2010143A2 Stabilized ophthalmic compositions comprising oxidatively unstable components |
| 01/07/2009 | EP2010142A2 Polyesteramide platform for site specific drug delivery |
| 01/07/2009 | EP2010141A2 High-deposition compositions and uses thereof |
| 01/07/2009 | EP2010133A2 Foamable suspension gel |
| 01/07/2009 | EP1718568A4 Process for preparing water soluble diterpenes and their applications |
| 01/07/2009 | EP1699529B1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
| 01/07/2009 | EP1581790B1 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 01/07/2009 | EP1575597B1 Use of rimexolone in the treatment of dry eye |
| 01/07/2009 | EP1560854B1 Taxanes covalently bound to hyaluronic acid or hyaluronic acid derivatives |
| 01/07/2009 | EP1539101B1 Injectable multimodal polymer depot compositions and uses thereof |
| 01/07/2009 | EP1503737B1 Nanoparticulate nystatin formulations |
| 01/07/2009 | EP1499291B1 Methods and dosage forms for controlled delivery of oxycodone |
| 01/07/2009 | EP1496942B1 Microparticles comprising carbohydrate beads covalently linked with allergen derived from plant pollen |
| 01/07/2009 | EP1492511B1 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 01/07/2009 | EP1476197B1 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 01/07/2009 | EP1407008B1 Influenza vaccine composition |
| 01/07/2009 | EP1341521B1 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | CN101340934A Immuno-RNA-constructs |
| 01/07/2009 | CN101340933A Factor xa inhibitor inclusion complex with cyclodextrin |
| 01/07/2009 | CN101340932A Carrier for medicaments for obtaining oral bioavailability |
| 01/07/2009 | CN101340916A Preparation for external use having improved temporal stability of steroid |
| 01/07/2009 | CN101340900A Nanoscale particles used as contrasting agents in magnetic resonance imaging |
| 01/07/2009 | CN101340899A Orally disintegrating tablet comprising fat-soluble substance |
| 01/07/2009 | CN101340893A Intranasal administration of rapid acting insulin |
| 01/07/2009 | CN101340892A Use of a liquid allergy vaccine formulation for oromucosal administration |
| 01/07/2009 | CN101340882A Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 01/07/2009 | CN101338459A Method for preparing organic and inorganic nanometer assorted fibre |
| 01/07/2009 | CN101338045A Technique of preparing cassava starch plant gum, the plant gum prepared thereby and plant capsules |
| 01/07/2009 | CN101337994A Starch acetate/PPDO-grafted copolymer, preparation method and application thereof |
| 01/07/2009 | CN101337076A Functional dendritic polymer gene vector system of targeted malignant cerebroma |
| 01/07/2009 | CN101337075A Liquid state vitamine C and production method thereof |
| 01/07/2009 | CN101337074A New use of polyvinylpyrrolidone in pharmacy |
| 01/07/2009 | CN101337073A Use of xylitol in pharmacy |
| 01/07/2009 | CN101337072A Preparation method of sustained and controlled release medicine material |
| 01/07/2009 | CN101337070A Freeze-dried attenuated live vaccine for hepatitis A and its preparing process |
| 01/07/2009 | CN101337067A Compound temperature sensitive type in-situ gel nasal-cavity administration preparation for treating osteoporosis |
| 01/07/2009 | CN101337066A Glutathion instant gel for eye |
| 01/07/2009 | CN101337031A Baicao pill |
| 01/07/2009 | CN101336995A Plaster for treating lumbar intervertebral disc protrusion |
| 01/07/2009 | CN101336994A Houttuynia instant gel for eye |
| 01/07/2009 | CN101336968A Preparation method of lipid microspheres combined by salvia lipid extract and poppy seed oil |
| 01/07/2009 | CN101336961A Coronary heart disease drop pill and preparation method thereof |
| 01/07/2009 | CN101336950A Oral nano raw baizhu colon tablet and preparation method thereof |
| 01/07/2009 | CN101336944A Xiaoxingzhang eye instant gel |
| 01/07/2009 | CN101336943A Evening primrose oil liquid capsule capable reducing blood sugar, blood fat and weight and preparation method thereof |
| 01/07/2009 | CN101336934A Bear bile buccal tablet and preparation process thereof |
| 01/07/2009 | CN101336931A Iron liposomes used as iron supplementary and preparation method thereof |
| 01/07/2009 | CN101336930A Organic and inorganic compound nano fibrous type antidiarrheics and preparation method thereof |
| 01/07/2009 | CN101336926A Anticancer composition loaded with bortezomib and alkyl agent |
| 01/07/2009 | CN101336923A Eye in-situ gel of pirenoxine sodium |
| 01/07/2009 | CN101336920A Stable medicine combination |
| 01/07/2009 | CN101336919A Phacolysin eye in-situ gel |
| 01/07/2009 | CN101336912A Eye in-situ gel of compound taurine |
| 01/07/2009 | CN101336911A Compound sustained-released injection containing marimastat as neovascularization inhibitor |
| 01/07/2009 | CN101336907A Patch and patch preparation |
| 01/07/2009 | CN101336906A Patch and patch preparation |
| 01/07/2009 | CN101336905A Production method of alpha-linolenic acid microcapsule |
| 01/07/2009 | CN101336902A Liposomes sodium morrhuate |
| 01/07/2009 | CN101336900A Anticancer sustained-released injection containing taxane |
| 01/07/2009 | CN101336899A Anticancer sustained-released injection containing taxane |
| 01/07/2009 | CN101336898A Anticancer sustained-released formulation loaded with platinum compound and synergist thereof |
| 01/07/2009 | CN101336895A Novel alkalized solid-liquid two-state skin quick-anaesthesia nano-emulsion and preparation method thereof |
| 01/07/2009 | CN101336894A Anticancer composition containing platinum compound and bortezomib |
| 01/07/2009 | CN101336893A Sustained-released injection containing bortezomib and topology enzyme inhibitor |
| 01/07/2009 | CN101336892A Gel injection of sustained-released topology enzyme inhibitor and preparation method thereof |
| 01/07/2009 | CN101336891A Anticancer sustained-released gel injection and preparation method thereof |
| 01/07/2009 | CN101336890A Anticancer sustained-release gel injection |
| 01/07/2009 | CN101336886A Soluble preparation of breviscapine |
| 01/07/2009 | CN101336885A Preparation method of microelement nano fibrofelt |
| 01/07/2009 | CN101336884A Preparation method of microelement nano fibrofelt |
| 01/07/2009 | CN100448482C Freeze dried HGF preparations |
| 01/07/2009 | CN100448455C Method for preparing coating particles for lowering moisture-absorption of Chinese medicine extract |
| 01/07/2009 | CN100448448C Mesalazine controlled release oral pharmaceutical compositions |
| 01/07/2009 | CN100448447C Preparation of superfine prednisolone powder |
| 01/07/2009 | CN100448443C Nanometer antifungal econazole nitrate emulsion medicine and its prepn process |